scholarly journals Kinetic Determinants of Agonist Action at the Recombinant Human Glycine Receptor

2003 ◽  
Vol 549 (2) ◽  
pp. 361-374 ◽  
Author(s):  
Trevor M. Lewis ◽  
Peter R. Schofield ◽  
Annette M. L. McClellan
2019 ◽  
Author(s):  
Jie Yu ◽  
Hongtao Zhu ◽  
Remigijus Lape ◽  
Timo Greiner ◽  
Rezvan Shahoei ◽  
...  

SummaryThe glycine receptor is a pentameric, neurotransmitter-activated ion channel that transitions between closed/resting, open and desensitized states. Glycine, a full agonist, produces an open channel probability (Po) of ∼1.0 while partial agonists, such as taurine and γ-amino butyric acid (GABA) yield submaximal Po values. Despite extensive studies of pentameric Cys-loop receptors, there is little knowledge of the molecular mechanisms underpinning partial agonist action and how the receptor transitions from the closed to open and to desensitized conformations. Here we use electrophysiology and molecular dynamics (MD) simulations, together with a large ensemble of single particle cryo-EM reconstructions, to show how agonists populate agonist-bound yet closed channel states, thus explaining their lesser efficacy, yet also populate agonist-bound open and desensitized states. Measurements within the neurotransmitter binding pocket, as a function of bound agonist, provide a metric to correlate the extent of agonist-induced conformational changes to open channel probability across the Cys-loop receptor family.


Cell ◽  
2021 ◽  
Vol 184 (4) ◽  
pp. 957-968.e21 ◽  
Author(s):  
Jie Yu ◽  
Hongtao Zhu ◽  
Remigijus Lape ◽  
Timo Greiner ◽  
Juan Du ◽  
...  

2019 ◽  
Vol 16 (10) ◽  
pp. 1167-1174 ◽  
Author(s):  
Kamil J. Kuder ◽  
Tadeusz Karcz ◽  
Maria Kaleta ◽  
Katarzyna Kiec-Kononowicz

Background: : One of the best known to date GPCR class A (Rhodopsin) includes more than 100 orphan receptors for which the endogenous ligand is not known or is unclear. One of them is N-arachidonyl glycine receptor, named GPR18, a receptor that has been reported to be activated by Δ9-THC, endogenous cannabinoid receptors agonist anandamide and other cannabinoid receptor ligands suggesting it could be considered as third cannabinoid receptor. GPR18 activity, as well as its distribution might suggest usage of GPR18 ligands in treatment of endometriosis, cancer, and neurodegenerative disorders. Yet, so far only few GPR18 antagonists have been described, thus only ligand-based design approaches appear to be most useful to identify new ligands for this orphan receptor. Methods: : Main goal of this study, GPR18 inactive form homology model was built on the basis of the evolutionary closest homologous template: Human P2Y1 Receptor crystal structure. Results: : Obtained model was further evaluated and showed active/nonactive ligands differentiating properties with acceptable confidence. Moreover, it allowed for preliminary assessment of proteinligand interactions for a set of previously described ligands. Conclusion:: Thus collected data might serve as a starting point for a discovery of novel, active GPR18 blocking ligands.


2021 ◽  
pp. 174175
Author(s):  
Lu Yao ◽  
Zhuoyan Fan ◽  
Shiwen Han ◽  
Na Sun ◽  
Huilian Che

Sign in / Sign up

Export Citation Format

Share Document